[Current trends in therapy and prophylaxis of immunological disorders in malignant hemoreticulopathies].
D000235:Adenolymphoma / Q000276:immunology; D000818:Animals; D000917:Antibody Formation; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology*; D007945:Leukemia, Lymphoid / Q000276:immunology*; D008206:Lymphatic Diseases / Q000276:immunology; D008223:Lymphoma / Q000276:immunology*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology; D009196:Myeloproliferative Disorders / Q000276:immunology*; D010587:Phagocytosis; D008258:Waldenstrom Macroglobulinemia / Q000276:immunology; D005719:gamma-Globulins / Q000032:analysis
D005719:gamma-Globulins
Orientări actuale în terapia şi profilaxia tulburărilor imunologice din hemoreticulopatiile maligne.